Currently out of the existing stock ratings of Daniel Markowitz, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).

Daniel Markowitz

Work Performance Price Targets & Ratings Chart

Analyst Daniel Markowitz, currently employed at EVERCORE, carries an average stock price target met ratio of 56.46% that have a potential upside of 19.01% achieved within 90 days.

Daniel Markowitz’s has documented 88 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on NTRA, Natera at 07-Aug-2026.

Wall Street Analyst Daniel Markowitz

Analyst best performing recommendations are on TECH (BIO-TECHNE CORP).
The best stock recommendation documented was for TECH (BIO-TECHNE CORP) at 5/7/2026. The price target of $50 was fulfilled within 1 day with a profit of $0.91 (1.79%) receiving and performance score of 17.87.

Average potential price target upside

of $68.34 (27.84%) on WST (WEST PHARMACEUTICAL SERVICES).
of $45.27 (23.63%) on NTRA (NATERA).
of $20.93 (30.41%) on INSP (INSPIRE MEDICAL SYSTEMS).

GH Guardant Health INSP Inspire Medical Systems NTRA Natera PODD Insulet RGEN Repligen RMBS Rambus TECH Bio-Techne Corp TMDX TransMedics Group WST West Pharmaceutical Services

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Casey Woodring (JPMORGAN)